v3.26.1
Loss Per Common Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Earnings Per Share [Abstract]        
Loss before preferred dividends and accretion of Series A Preferred Stock $ (28,364) $ (19,897) $ (54,996) $ (84,515)
Dividends and accretion of Series A Preferred Stock 0 (31,193) 0 (38,825)
Net loss attributable to common shareholders of Evolent Health, Inc. - basic (28,364) (51,090) (54,996) (123,340)
Net loss attributable to common shareholders of Evolent Health, Inc. - diluted $ (28,364) $ (51,090) $ (54,996) $ (123,340)
Weighted-average common shares outstanding - basic (in shares) 112,542 115,882 112,225 115,600
Weighted-average common shares outstanding - diluted (in shares) 112,542 115,882 112,225 115,600
Basic and diluted        
Basic (in dollars per share) $ (0.25) $ (0.44) $ (0.49) $ (1.07)
Diluted (in dollars per share) $ (0.25) $ (0.44) $ (0.49) $ (1.07)